Probiota Asia 2018

WATCH — 'A daunting task': IPA chief on the challenges of commercialising a global probiotic product

This content item was originally published on, a William Reed online publication.

By Gary Scattergood

- Last updated on GMT

Related tags Probiotics commercialisation

Companies seeking to commercialise a probiotic product across the globe face a 'daunting task', which is why trade association the International Probitics Association (IPA) is vowing not to let up in its efforts to achieve a more consistent global regulatory regime.

NIA-GOED Omega-3 Summit

NutraIngredients, in conjunction with GOED, will be holding APAC's first ever omega-3 event in Singapore in February 2019, featuring renowned speakers from CSIRO, A*STAR, Koure, GOED and more.

Find out how to attend​.

The organisation's executive director George Paraskevakos was a keynote speaker at our Probiota Asia summit in Singapore, where he gave an overview of the current rules across the globe.

"It's incredibly difficult,"​ he said. "Even if you take a look at the permitted lists of strains, there is huge variation."

We spoke with Paraskevakos after his presentation, where he provided an update on the organisation's efforts to usher in a more harmonised regime through CODEX, and revealed some recent advances in the US rules.

He also discusses the current market performance of probiotics across Asia Pacific, and the booming China sector in particular.

Related news

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Follow us


View more